Myolespen
Myolespen Brand names, Myolespen Analogs
- Alinam
- Banabil-sintyal
- Banabin
- Banabin-Sintyal
- Banabin-syntyal
- Bisina
- Chlomedinon
- Chlormethazanone
- Chlormethazone
- Chlormezanon
- Chlormezanone [BAN:INN:JAN]
- Chlormezanonum [INN-Latin]
- Clorilax
- Clormetazanone
- Clormetazon
- Clormezanona [INN-Spanish]
- Clormezanone [DCIT]
- Dichloromethazanone
- Dichloromezanone
- Fenarol
- Lobak
- Mio-Sed
- Miorilax
- Muskel
- Muskel-Trancopal
- Myolespen
- Phenarol
- Rexan
- Rilansyl
- Rilaquil
- Rilasol
- Rilassol
- Rilax
- Rillasol
- Supotran
- Suprotan
- Tanafol
- Trancopal
- Trancote
- Tranrilax
- Transanate
- dl-Chlormezanone
Myolespen Brand Names Mixture
- No information avaliable
Myolespen Chemical_Formula
C11H12ClNO3S
Myolespen RX_link
No information avaliable
Myolespen fda sheet
Myolespen msds (material safety sheet)
Myolespen Synthesis Reference
No information avaliable
Myolespen Molecular Weight
273.737 g/mol
Myolespen Melting Point
116.2 oC
Myolespen H2O Solubility
2500 mg/L (hardly soluble)
Myolespen State
Solid
Myolespen LogP
1.208
Myolespen Dosage Forms
No information avaliable
Myolespen Indication
Used in the management of anxiety and in the treatment of muscle spasm.
Myolespen Pharmacology
Chlormezanone is a non-benzodiazepine muscle relaxant. It was discontinued worldwide in 1996 by its manufacturer due to confirmed serious and rare cutaneous reactions (toxic epidermal necrolysis).
Myolespen Absorption
No information avaliable
Myolespen side effects and Toxicity
Symptoms of overdose include drowsiness, weakness, nausea, dizziness, abdominal pain, cerebral oedema and renal tubular necrosis, hyperglycaemia and hypoglycaemia, liver damage, encephalopathy, coma and death.
Myolespen Patient Information
No information avaliable
Myolespen Organisms Affected
Humans and other mammals
